> News > abc biopply and SEED Biosciences collaborate on the automated individualization of highly homogenous and uniform spheroids
03.02
2022

abc biopply and SEED Biosciences collaborate on the automated individualization of highly homogenous and uniform spheroids

abc biopply and SEED Biosciences collaborate on the automated individualization of highly homogenous and uniform spheroids

SEED Biosciences and abc biopply recently started a collaboration to develop highly homogeneous spheroids for high-throughput screening applications.

The companies’ combined expertise will allow the integration of 3D spheroid cultures in large-scale compound screening programs.

This approach will generate spheroids that more accurately reflect the physiological conditions of the cells, allowing more reliable preclinical test results.

abc biopply and SEED Biosciences have signed a letter of intent to collaborate on the separation and individualization of living spheroids for use in high-throughput screening (HTS) applications. By bringing together their specialized knowledge, the companies aim to tackle the challenge of growing uniform spheroids to allow more reliable large-scale 3D culture compound screening.

Read Press Release

Company related to the news